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Background: A proportion of deliberate self-poisoning (DSP) patients present repeatedly to the emergency
department (ED). Understanding the characteristics of frequent DSP patients and their presentation is a first step to
implementing interventions that are designed to prevent repeated self-poisoning.
Methods: All DSP presentations to three networked Australian ED’s were retrospectively identified from the ED
electronic medical record and hospital scanned medical records for 2011. Demographics, types of drugs ingested,
emergency department length of stay and disposition for the repeat DSP presenters were extracted and compared
to those who presented once with DSP in a one year period. Logistic regression was used to analyse repeat versus
single DSP data.
Results: The study determined 755 single presenters and 93 repeat DSP presenters. The repeat presenters
contributed to 321 DSP presentations. They were more likely to be unemployed (61.0% versus 39.9%, p = 0.008) and
have a psychiatric illness compared to single presenters (36.6% versus 15.5%, p < 0.001). Repeat presenters were less
likely to receive a toxicology consultation (11.5% versus 27.3%, p < 0.001) and were more likely to abscond from the
ED (7.5% versus 3.4%, p = 0.004). Repeat presenters were more likely to ingest paracetamol and antipsychotics than
single presenters. The defined daily dose for the most common antipsychotic ingested, quetiapine, was less in the
repeat presenter group (median 1.9 [IQR: 1.3-3.5]) compared with the single presenter group (4 [1.4-9.5]), (OR 0.85,
95% CI 0.74-0.99).
Conclusion: Patients who present repeatedly to the ED with DSP have pre-existing disadvantages, with increased
likelihood of being unemployed and having a mental illness. These patients are also more likely to have health
service inequities given the greater likelihood to abscond from the ED and lower likelihood of receiving toxicology
consultation for their DSP. Early recognition of repeat DSP patients in the ED may facilitate the development of
individualised care plans with the aim to reduce repeat episodes of self-poisoning and subsequent risk of successful
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Deliberate self-poisoning (DSP) is a common cause for
frequent presentations to the emergency department
(ED), placing an increased burden on the ED [1]. Self-
poisoning is the most common method of deliberate
self-harm [2]. Presentation with DSP is often perceived
negatively by staff involved in the treatment of these pa-
tients [3]. Staff attitudes and the patient’s ED experience
have been shown to influence the patient’s decision to
stay for treatment [4]. A poor ED experience may also
exacerbate repeated self-harm behaviour [4]. In addition,
an adverse experience may influence whether the pa-
tient seeks medical assistance for future self-harm [4].
These findings are significant considering that repeat
self-poisoning behaviour results in an increased risk
of subsequent successful suicide [5,6].
In an era of increasing demand on the ED [7] and in-
troduction of efficiency initiatives such as the 4-hour
rule [8], understanding and describing frequent presen-
ters is an important first step towards development and
implementation of strategies to reduce re-attendances.
Therefore, the aim of this study was to examine presen-
tations to three Australian ED’s, in a one-year period by
repeat DSP status. Characteristics examined were 1) pa-
tient characteristics, including age, gender, employment
and psychiatric history; 2) presentation characteristics,
including length of stay (LOS) data and disposition from
the ED; 3) ED interventions with occurrence of psychi-
atric and toxicological consultations; and 4) type and
amount of medications taken in the DSP.
Methods
This study was a retrospective chart review of DSP
presentations to Monash Health’s three emergency de-
partments from January 1st 2011 to December 31st 2011.
Ethical approval for the study was obtained from Monash
Health Human Research and Ethics Committee and Aus-
tralian Catholic University. The definition of DSP was
based on National Institute for Health and Clinical Excel-
lence (NICE) definition of self-harm where self-harm is
defined as ‘any act of self-poisoning or self-injury carried
out by an individual irrespective of motivation’ [4]. Repeat
poisoning presentations (RPP) were defined as greater
than one presentation with DSP in 2011 to any of the
three ED’s. A single presentation in 2011, following
an episode of DSP, was termed single poisoning pres-
entation (SPP).
A search of the Monash Health’s emergency department
electronic database (SYMPHONY Version 2.29, Ascribe
plc, Bolton, UK) was conducted to identify DSP presenta-
tions. Patients were included if aged ≥ 18 years presenting
to Monash Health’s three EDs in 2011 with a presenting
complaint of 1) Mental Health involuntary assessment re-
quired, 2) Mental Health voluntary requesting treatmentor self-harm, 3) overdose/ingestion/poison/toxic exposure
were included. The triage notes of each presentation were
then screened and those deemed as accidental, recrea-
tional and non-DSP presentations were removed. This
included presentations requesting psychiatric help or
presentations for irrational/disturbed behaviour. Each
DSP patient identified from the initial screening then had
all their ED presentations in 2011 examined in Scanned
Medical Records (SMR) for any missed DSP presentations.
Emergency and hospital information about each DSP
presentation was obtained from Monash Health SMR.
This was then entered into a clinical database specifically
designed for toxicology data acquisition. The database in-
cluded information about the patient’s demographics, pre-
vious psychiatric history, toxins taken and amounts,
admission and discharge dates, toxicology and psychiatric
consults, critical care required, ventilation support re-
quired, discharge outcome and follow-up.
Age, employment, and marital status were determined
at the index visit. The index visit was defined as the
first presentation with DSP to the ED in 2011. The un-
employed group included those patients who had identi-
fied themselves as unemployed or were on a disability
support pension. These items were categorised together
as a disability support pension may represent “hidden
unemployment” [9]. Employement status distribution
was analysed by repeat status. A secondary analysis was
also undertaken where patients were categorised into
unemployed and ‘other’. ‘Other’ was defined as either
being either a student, employed, retired or undertaking
home duties. Marital status was categorised into married/
de facto relationship or single (single/widowed/separated/
divorced).
Previous psychiatric history was obtained from emergen-
cy Enhanced Crisis Assessment Treatment Team (ECATT)
or psychiatric notes from SMR. A person was deemed to
have a previous psychiatric illness if they had docu-
mented personality disorder, bipolar affective disorder
or schizophrenia.
LOS was determined for 1) patients discharged home
from the ED, 2) total hospital LOS for patients admitted
to a general ward without requiring critical care stay
(time spent in ED and general ward stay) and 3) total
hospital stay for patients who required critical care stay
(time spent in ED, critical care ward and general ward
stay). LOS in the ED was defined as the time spent in
ED and short stay unit (observation area of the ED) and
was determined as the time recorded on arrival to the
ED and discharge time from the ED. Patients staying
overnight in ED short-stay/observation unit were consid-
ered non-admitted patients. LOS for patients admitted
to the hospital was determined from SMR as ED arrival
time to the time of discharge from the hospital docu-
mented in the patients’ medical records. If no discharge
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the clinical database. This time was chosen as it was the
median discharge time determined for patients dis-
charged from hospital wards with a documented dis-
charge time.
Drugs ingested were categorised into major drug clas-
ses. The most common specific agents in each drug class
were also examined. Drugs were described by presenta-
tion, that is, what percentage of presentations involved
ingestion of a particular class of medication. Daily de-
fined dose (DDD) was determined from the Anatomical
Therapeutic Chemical/Defined Daily Dose (ATC/DDD)
index 2014 World Health Organisation Collaborating
Centre for Drug Statistics Methodology website [10].
Comparison of DDD between RPP and SPP was underta-
ken. A separate analysis of the DDD was also undertaken
for patients with multiple frequent DSP presentations to
the ED compared with SPP. Multiple frequent DSP at-
tendance was defined as five or more presentations with
DSP in 2011 [11].
Summary categorical statistics are expressed as num-
ber (percentage). Continuous data were examined for
normality using the Shapiro-Wilk and Shapiro-Francia
tests. Summary continuous statistics are expressed as
mean ± standard deviation if normally distributed or me-
dian [inter-quartile range (IQR)] if not. Univariate lo-
gistic regression was used to analyse the relationship
between all potential predictor variables and the binary
outcome variable, RPP versus SPP. The effect size was
described as odds ratio (OR) and 95% confidence inter-
val (CI). Statistical significance was considered if the
95% CI included the value one. Hosmer-Lemeshow good-
ness of fit test was used to assess fit of logistic regression
model. Variables were also examined for frequency of
missing data. Except for LOS missing data, where single
imputation was performed as explained above, com-
plete case analysis was used to handle missing data
[12]. Data analysis was performed using Stata version
12 (Stata Corporation, TX, USA).Results
Presentations of DSP
A total of 1076 DSP presentations were identified for
2011 (see Figure 1). The majority of these presentations
were SPP patient presentations (n = 755, 89.0%) in 2011;
whereas 93 RPP patients (11.0%) contributed to 321 pre-
sentations (see Table 1). The RPP frequency ranged from
2 to 31 presentations, with a median number of 2 [IQR:
2-3] presentations. Sixty-four patients presented twice;
26 patients presented 3 to 9 times, which contributed to
116 presentations and three patients contributed to 77
presentations in 2011. Forty-two percent of the SPP’s
ingested more than one toxin in the DSP, whereas 45%of the RPP group ingested more than one toxin (OR
1.13, 95% CI: 0.65-1.98).
Characteristics of DSP patients
No difference was found in the distribution of employ-
ment status between the RPP and SPP groups, however
when the patients were categorised into unemployed
and ‘other’ the RPP patients were more likely to be un-
employed than the SPP group (OR 2.36, 95% CI: 1.45-
3.85). The RPP patients were more likely to have a previ-
ous diagnosis of personality disorder, bipolar affective
disorder or schizophrenia than SPP patients (OR 3.05,
95% CI: 1.92-4.85). Although median age was not statis-
tically different between the SPP and RPP groups the
RPP group were all younger than 60 years of age (see
Table 1).
Table 2 shows that RPP patients were more likely to
abscond from the ED and were less likely to have re-
ceived a Toxicology consultation for their acute poison-
ing presentation.
Length of stay
Although not statistically different, the ED LOS for pa-
tients who were discharged home from the ED tended to
be higher in the RPP group (Table 2). The total hospital
stay for patients requiring critical care admission was
higher in the RPP group compared with the SPP group
(OR 1.15, 95% CI: 1.10-1.31). One patient in the RPP
group contributed to three critical care stays.
Type and amount of medication used in DSP
As a group, benzodiazepines were the most commonly
reported toxicant ingested in DSP in 2011 for both the
SPP and RPP groups (see Table 3). Diazepam was the
most commonly ingested benzodiazepine in both groups
but the RPP group had higher DSP presentations associ-
ated with diazepam than the SPP group (OR 1.66, 95%
CI 1.23-2.25). RPP’s were more likely to ingest paraceta-
mol than SPP patients (OR 1.37, 95% CI: 1.03-1.84) and
less likely to take antidepressants (OR 0.64, 95% CI:
0.47-0.88) in overdose. Co-ingestion with alcohol during
DSP was high and similar for both groups. Although not
statistically different, the RPP patients tended to have a
higher number of overdose presentations associated with
antipsychotic agents. Quetiapine was the most common
antipsychotic ingested for both groups. However, RPP
patients more commonly ingested quetiapine for DSP
(OR 1.63, 95% CI: 1.06-2.50). Interestingly, the median
ingested DDD was lower in the RPP group than for SPP
group (median 1.9 [IQR: 1.3-3.5] versus 4 [1.4-9.5], OR
0.85 95% CI: 0.74-0.99) (see Table 4). There was no sig-
nificant difference in reported median DDD ingested
between the two groups for any of the other classes
of medications.
Figure 1 Flowchart summarizing how DSP presentations to the ED in 2011 were determined. DSP: deliberate self-poisoning, ED: Emergency
Department, SMR: Scanned Medical Records.
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A separate analysis for those with five or more DSP presen-
tations in 2011 showed that these patients took more DDDs
of Paracetamol compared to SPP patients (median 3.8 [IQR:
2.6-6] versus 2.2 [IQR: 1.3-4.4]; OR 1.14, 95% CI: 1.04-1.25).
Inpatient mortality from DSP
There were no inpatient deaths as a result of DSP during
the study period.Missing data
The majority of variables examined had none or few miss-
ing data points as data is collected for key performance in-
dicators for the ED. Variables with the most missing data
included marital status (6.8%), employment status (19.6%),
toxicology consultation (12.9%) and psychiatric consul-
tations (23.2%). For the variables marital status and em-
ployment, the majority of missing data occurred in the
SPP group.







General ward 86 (11.4)






Psychiatric consult 457 (60.5)
Toxicology consult 205 (27.3)
LOS
ED€ (hours) 6.5 [4.4-10.8]
Non critical care admission§ (days) 1.9 [1.3-3.8]
Critical care admissionδ (days) 2.6 [1.8-3.9]
Data presented as number (%) or median [interquartile range]. ¥Univariate logistic r
from ED. §Total hospital LOS, including ED for patients admitted to a general ward;
HDU), includes ED and ward stay post critical care.. SPP: Single poisoning presentati
dependency unit, CCU: Coronary care unit, DSP: Deliberate self-poisoning, LOS: Leng
Table 1 Characteristics of patients presenting with
deliberate self-poisoning in 2011
SPP RPP OR¥ 95% CI¥
Number 755 93
Age 35.0 [23.7-45.0] 37.0 [26.1-43.6] 0.99 0.98-1.01
Female 485 (64.2) 60 (64.5) 1.10 0.70-1.72
Marital Status
Married/ Defacto 274 (39.4) 30 (32.6) 1.13 0.47-1.18
Single€ 422 (60.6) 62 (67.4)
Employment 1.17§ 0.97-1.41§
Employed 237 (40.7) 22 (28.6)
Student 50 (8.6) 3 (3.9)
Unemployed 232 (39.9) 47 (61.0)
Retired/Pensioner 20 (3.4) 0 (0)
Home duties 43 (7.4) 5 (6.5)
Unemployedδ 232 (39.9) 47 (61.0) 2.36 1.45-3.85
Psychiatric history£ 120 (15.5) 34 (36.6) 3.05 1.92-4.85
Data presented as number (%) or median [inter-quartile range]. ¥Univariate
logistic regression test of SPP versus; €Single includes widows/separated/
divorced; §Statistical test of employment distribution; δStatistical test of
unemployed versus ‘others’; £Psychiatric history includes personality disorder,
bipolar affective disorder or schizophrenia. SPP: Single poisoning presentation,
RPP: Repeat poisoning presentation.
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This study confirms the results of a number of previous
studies examining DSP repeat presenters observing that,
this patient group was more likely to be unemployed
and have a mental health illness compared to those pre-
senting only once [13,14]. This study found that RPP pa-
tients were more likely to be disadvantaged in other
ways such as, they were more likely to abscond before
care was completed and less likely to have a toxicology
assessment even though similar doses of drug were in-
gested for most classes of medication. A similar severity
of poisoning in both patient groups is suggested by the
fact that ingested drug dose for most toxins was similar
and the frequency of ICU admission was also not signifi-
cantly different.
The proportion of DSP patients with recurrent presen-
tations in the same year in this study was similar to that
reported in other studies [14-17]. However, two studies
reported higher re-presentation proportions [13,18]. One
of these reported that 21% of DSP patients had recurrent
presentations; however this was a retrospective study
with a study period of ten years, which may have influ-
enced the result [13]. The other study reported that 18%
of DSP patients re-presented. The difference in represen-
tation proportion may be due to the prospective nature of
the study as DSP patients, who met the study inclusion
criteria, were consented to be followed over time [18].ngth of stay
RPP OR¥ 95% CI¥
321
187 (58.3) 0.89 0.64-1.23
18 (5.6) 0.77 0.44-1.34
8 (2.5) 0.50 0.23-1.08
40 (12.5) 1.11 0.74-1.65
38 (11.8) 0.90 0.60-1.34
13 (4.1) 0.95 0.49-1.84
24 (7.5) 2.28 1.28-4.05
12 (3.7) 1.13 0.56-2.28
2 (0.6) NT
193 (60.1) 0.98 0.75-1.28
37 (11.5) 0.35 0.24-0.51
7.2 [4.3-12.6] 1.02 0.99-1.06
1.8 [1.6-2.8] 0.85 0.70-1.04
4.8 [2.5-5.9] 1.15 1.01-1.31
egression test of SPP versus RPP; €LOS in ED for patients discharged home
δTotal hospital LOS for patients requiring a critical care admission (CCCU/ICU/
on, RPP: Repeat poisoning presentation, ICU: Intensive care unit, HDU: High
th of stay, ED: Emergency department includes short-stay area, NT: Not tested.
Table 3 Comparison of drugs ingested by class for single and repeat presenters
Drug Class Most common specific agents in class SPP€ presentations (N = 752) RPP€ presentations (N = 315) OR¥ 95% CI¥
Benzodiazepines 296 (39.4) 135 (42.9) 1.12 0.85-1.46
Diazepam 146 (19.4) 90 (28.6) 1.66 1.23-2.25*
Temazepam 74 (9.8) 24 (7.6) 0.76 0.47-1.22
Alprazolam 64 (8.5) 21 (6.7) 0.76 0.46-1.28
Alcohol (Beverage) 245 (32.5) 95 (30.0) 0.89 0.67-1.19
Paracetamol 179 (23.8) 96 (30.5) 1.37 1.03-1.84*
Antidepressants 217 (28.9) 65 (20.6) 0.64 0.47-0.88*
SSRI£ 89 (11.8) 20 (6.3) 0.51 0.31-0.84*
Escitalopram/Sertraline 51 (6.8) 15 (4.8) 0.69 0.38-1.24
SNRI Venlafaxine/Desvenlafaxine/Duloxetine§ 47 (6.3) 19 (6.0) 0.96 0.56-1.67
TCA 39 (5.2) 7 (2.2) NT
Antipsychotics 99 (13.2) 55 (17.5) 1.40 0.97-2.00
Quetiapine 60 (8.0) 39 (12.4) 1.63 1.06-2.50*
Olanzapine 11 (1.5) 7 (2.2) NT
NSAIDs 81 (10.8) 30 (9.5) 0.87 0.56-1.36
Other drugs 266 (35.4) 100 (31.8) 0.85 0.64-1.12
Opioids 61 (8.1) 11 (3.5) 0.41 0.21-0.79*
Zolpidem/Zopiclone 32 (4.3) 13 (4.1) 0.97 0.50-1.87
Data presented as number (%). ¥Univariate logistic regression test of SPP versus RPP, €Data missing: three for single presenters and 6 for repeat presenters,
information either not in scanned medical records or described as unknown, *Significant difference, £Data presented for all SSRI and the three most common
ingested, §Only these SNRI’s ingested in DSP. SPP: Single poisoning presentation, RPP: Repeat poisoning presentation, OR: Odds ratio, CI: Confidence interval, SSRI:
Serotonin-specific reuptake inhibitor, SNRI: Serotonin–norepinephrine reuptake inhibitor, TCA: Tricyclic antidepressants, NSAID: Non-steroidal anti-inflammatory, NT:
Not tested. Note: frequencies add up to greater than 100% as DSP may be associated with more than one toxin.
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that RPP patients were more likely to be unemployed
[13,18,19], single [14], live alone [20], or have a psychi-
atric history [13,18,19]; particularly personality disorder
or schizophrenia [19] than SPP patients.Table 4 Comparison of amount of drug ingested for
single and repeat deliberate self-poisoning presenters
defined by daily dose of drug (DDD)
N SPP N RPP OR¥ 95% CI¥
Benzodiazepine 217 6 [4-14] 101 10 [5-16] 1.01 1.00-1.02
Diazepam 103 6 [3-15] 68 10 [4.4-15] 1.02 0.99-1.05
Temazepam 67 5.5 [3-10] 20 5.5 [2.8-12.3] 0.99 0.91-1.08
Alprazolam 35 10 [5-20] 13 24 [20-32] 1.01 1.00-1.03
Paracetamol 162 2.2 [1.3-4.4] 85 3.3 [1.7-5.0] 1.06 0.98-1.15
Antidepressant 147 15 [6-28] 42 20 [10-32] 1.01 0.99-1.02
SSRI 100 15 [7-28] 25 20 [10-25] 1.01 0.99-1.02
Antipsychotic 61 4.5 [1.8-10.5] 39 3 [1.3-5] 0.98 0.93-1.03
Quetiapine 40 4 [1.4-9.5] 26 1.9 [1.3-3.5] 0.85 0.74-0.99*
Anticonvulsant 25 4.5 [1.3-13.3] 12 7.3 [3.3-12.8] 1.00 0.92-1.09
Data presented as median [interquartile range]. ¥Univariate logistic regression
test of SPP versus RPP, *Statistically significant. N: Number, SPP: Single
poisoning presentation, RPP: Repeat poisoning presentation, OR: Odds ratio,
CI: Confidence interval.Gender and age differences in RPP patients have been
less consistent in previous studies, with two studies find-
ing no gender influence on RPP behaviour [15,16]. How-
ever, two other studies found the opposite, with female
gender being a significant factor in RPP behaviour [13,14].
Additionally, we found no association with age and RPP
status. This is consistent with another Australian study
[14]. Other studies have noted that RPP patients tended to
be older than SPP patients [15,19]. It is possible that there
are geographical and cultural differences between studies.
For example, the catchment area of the present study in-
cluded a large proportion of people born overseas [21].
However, it was beyond the scope of this study to examine
this further.
This study also found no difference between SPP and
RPP patients in their disposition from the ED. However,
an older study of self-poisoning found that RPP patients
were less likely to be admitted to a hospital ward than
SPP patients [15]. As RPP patients had lower triage cat-
egory scores than SPP patients the authors hypothesised
that RPP patients were less sick and hence less likely to
be admitted.
Differences in length of stay between SPP and RPP
groups have not been well characterised. A study under-
taken in 1999 examined hospital LOS of the index visit
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that the RPP group had statistically significant longer
hospital LOS than the SPP group, but the authors felt
the difference was not clinically significant [14]. Our
study found that RPPs had a significantly longer LOS if
critical care admission was required. However, the num-
ber of critical care admissions in the RPP group was not
large and one patient contributed to three critical care
admissions. In older studies of DSP patients, the propor-
tion of patients admitted to hospital was considerably
greater than in this study and other more contemporary
studies. A study from 20 years ago reported that 70% of
all DSP patients were admitted to an in-patient bed [16],
which was considerably higher than in the present study.
The lower in-patient admission rate may reflect the cur-
rent practice of utilising ED short stay or observation
units for patients with projected short lengths of stay
(<48 hours) as is often the case with DSP patients.
Very few studies have examined whether the charac-
teristics of toxicants ingested by SPP or RPP patients
vary. In a retrospective study that examined the cha-
racteristics of patients presenting with DSP to a South
Korean ED over a nine year period; the authors found
that RPP patients were more likely to ingest sedatives or
antidepressants whereas SPP patients tended to use sed-
atives or analgesics [13]. In an Australian study, the RPP
characteristics for patients presenting to a Victorian hos-
pital over a two-year period between 1993 and 1994 were
examined. Those with greater than one presentation with
DSP tended to take a single drug in the overdose com-
pared to those that presented once [15]; this was not the
case in this present study. However, similar to the current
study, paracetamol overdose was higher in the RPP group.
In another Australian study the class of drug ingested at
the index visit in SPP and RPP patients was examined
within one year period [14]. Benzodiazepines were most
commonly ingested followed by paracetamol in both
groups. In the RPP group, the third most common drug
class was antipsychotics, whereas for the SPP group it was
antidepressants [14]. This observation parallels the results
of our study. Our study shows that RPP had higher use of
quetiapine associated DSP but the ingested dose was lo-
wer in this group. Repeat DSP is often associated with
pre-existing mental health conditions, such as schizophre-
nia and bipolar affective disorder [19], which allows easier
access to antipsychotic prescription medication such as
quetiapine. Concerns about the trend of increased rates of
quetiapine prescribing and ambulance call outs associated
with quetiapine use in recent years have been raised in
Australia [22]. This study also reveals that although there
was no significant difference in overall benzodiazepine in-
gestion between the two groups, the RPP group had statis-
tically higher use of diazepam. This may reflect greater
access to this drug in recurrent presenters.Although there are methodological differences and over
a decade has lapsed between this current study and the
two previous Australian studies, they all show that the top
four classes of drugs used in DSP, excluding alcohol, are
benzodiazepine, paracetamol, antidepressants and antipsy-
chotics [14,15]. The impulsivity associated with DSP [23]
may explain why paracetamol was the second most com-
mon ingested medication for patients who had repeated
presentations following DSP in this current study.
This study confirms the results of other studies that al-
cohol co-ingestion is common in patients with DSP [1,23].
This current study found no difference in frequency of al-
cohol co-ingestion between the two groups, however, we
did not examine chronic alcohol use as a predictor for
RPP.
We recently reported that ED nursing and medical
staff felt empathy towards DSP patients who presented
once but frustration towards DSP patients who presen-
ted repeatedly [24,25]. The association of psychosocial
history, unemployment and psychiatric illness, and more
frequent absconding behaviour from the ED may result
in staff feeling that they are dealing with patients who
are difficult to manage, do not take responsibility for
their actions, and do not want help. This finding is es-
pecially significant for those patients who re-present on
numerous occasions. Many of the RPP patients were con-
sidered to be attention seeking, taking up resources and
some staff queried whether the ED was the right place for
these patients [24,25]. The sub-analysis of the most fre-
quent DSP attenders suggested that the severity of poison-
ing was similar to the single presenters. For those that
ingested paracetamol the ingested dose was greater in the
frequent repeat presenters, with a median DDD of 3.8.
This is within the range of expected toxic ingested dose
requiring antidote treatment [26]. This suggests risk as-
sessment in the ED is important in this group.
The ED has an important role in the recognition of
patients at risk of recurrent self-poisoning and re-
presentation to hospital. Detection of patients at risk
of re-harming may allow the implementation of evi-
dence based interventions designed to reduce this phe-
nomenon. This may include measures such as frequent
postcards sent to DSP patients, telephone follow up, or
follow up in self-harm clinics once discharged [27]. An in-
crease in the severity of repeat DSP is associated with in-
creased risk of future suicide completion [28]. As a result,
a database of DSP patient presentations could identify
those in the RPP group. Coupled with regular multidis-
ciplinary clinical meetings, this would facilitate the devel-
opment and implementation of specific care plans for
patients.
The retrospective nature of this study meant that we were
reliant on the integrity of the medical record data. The vari-
ables marital and employment status, documentation of
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http://www.biomedcentral.com/1471-227X/14/21toxicology and psychiatric consult, all had high levels of
missing data, which may have biased the results. Variables
regarding the type and amount of medications used in
DSP episodes were not collected for some patients, such
as those with altered conscious state, which may also have
influenced the results. We used the ED presenting diagno-
sis to determine self-poisoning presentations and may
have missed some patients presenting with DSP. Also, we
only examined repeat presentations in a one year period
and some patients in the single presentation group may
have re-presented beyond the boundaries of the study
time-frame. Patients may have presented to other hospital
networks during the study period, which means that pa-
tients identified as single presentations may actually be re-
current presenters. While there were no in-hospital deaths
in this cohort, we did not analyse coroner’s data to assess
for completed suicide following DSP in the community.
Variables that may have helped to explain repeater be-
haviour were not collected for this study. These included
previous DSP episodes, drug and alcohol history, and as-
sociated self-injury with the DSP. Therefore, further em-
pirical studies investigating those patients who present to
the ED following repeated DSP presentations are required.Conclusion
Our study provides more contemporary information re-
garding the characteristics of patients who present with
repeated self-poisoning in an Australian setting. This
patient group has pre-existing disadvantages, with in-
creased likelihood of being unemployed and having a
pre-existing mental health problem. They are also more
likely to have health service inequities given the greater
likelihood to abscond from the ED and lower likelihood
of receiving toxicology consultation for their poisoning.
However, repeat presenters had a similar severity of DSP
as determined by frequency of critical care admission
and similar doses and classes of drug ingested compared
to single presenters. ED staff are well placed to facilitate
the development and implementation of evidence based
intervention and specific care plans for these patients.Competing interests
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